Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 613

1.

Transplantation in highly sensitized patients: challenges and recommendations.

Heidt S, Claas FHJ.

Expert Rev Clin Immunol. 2018 Jul 13:1-7. doi: 10.1080/1744666X.2018.1498335. [Epub ahead of print]

PMID:
30004800
2.

Calcium-Binding Proteins S100A8 and S100A9: Investigation of Their Immune Regulatory Effect in Myeloid Cells.

Yang J, Anholts J, Kolbe U, Stegehuis-Kamp JA, Claas FHJ, Eikmans M.

Int J Mol Sci. 2018 Jun 21;19(7). pii: E1833. doi: 10.3390/ijms19071833.

3.

A subset of anti-HLA antibodies induces FcγRIIa-dependent platelet activation.

Rijkers M, Saris A, Heidt S, Mulder A, Porcelijn L, Claas FHJ, Bierings R, Leebeek FWG, Jansen AJG, Vidarsson G, Voorberg J, de Haas M.

Haematologica. 2018 Jun 1. pii: haematol.2018.189365. doi: 10.3324/haematol.2018.189365. [Epub ahead of print]

4.

How the definition of acceptable antigens and epitope analysis can facilitate transplantation of highly sensitized patients with excellent long-term graft survival.

Heidt S, Haasnoot GW, Claas FHJ.

Curr Opin Organ Transplant. 2018 Aug;23(4):493-499. doi: 10.1097/MOT.0000000000000545.

PMID:
29846197
5.

Genome-wide association studies in kidney transplantation: Advantages and constraints.

Yang J, Claas FHJ, Eikmans M.

Transpl Immunol. 2018 Apr 25. pii: S0966-3274(18)30048-0. doi: 10.1016/j.trim.2018.04.004. [Epub ahead of print]

PMID:
29704558
6.

Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report.

Tambur AR, Campbell P, Claas FH, Feng S, Gebel HM, Jackson AM, Mannon RB, Reed EF, Tinckam K, Askar M, Chandraker A, Chang PP, Colvin M, Demetris AJ, Diamond JM, Dipchand AI, Fairchild RL, Ford ML, Friedewald J, Gill RG, Glotz D, Goldberg H, Hachem R, Knechtle S, Kobashigawa J, Levine DJ, Levitsky J, Mengel M, Milford E, Newell KA, O'Leary JG, Palmer S, Randhawa P, Smith J, Snyder L, Starling RC, Sweet S, Taner T, Taylor CJ, Woodle S, Zeevi A, Nickerson P.

Am J Transplant. 2018 Jul;18(7):1604-1614. doi: 10.1111/ajt.14752. Epub 2018 May 22.

PMID:
29603613
7.

PIRCHE-II Is Related to Graft Failure after Kidney Transplantation.

Geneugelijk K, Niemann M, Drylewicz J, van Zuilen AD, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Hack CE, van Reekum FE, Verhaar MC, Kamburova EG, Bots ML, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed A, Lardy JNM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Spierings E.

Front Immunol. 2018 Mar 5;9:321. doi: 10.3389/fimmu.2018.00321. eCollection 2018.

8.

Human Cytomegalovirus Infection Increases Both Antibody- and Non-Antibody-Dependent Cellular Reactivity by Natural Killer Cells.

Michelo CM, van Cranenbroek B, Touw P, Claas FHJ, van der Meer A, Joosten I.

Transplant Direct. 2017 Nov 20;3(12):e335. doi: 10.1097/TXD.0000000000000750. eCollection 2017 Dec.

9.

Lower frequency of the HLA-G UTR-4 haplotype in women with unexplained recurrent miscarriage.

Meuleman T, Drabbels J, van Lith JMM, Dekkers OM, Rozemuller E, Cretu-Stancu M, Claas FHJ, Bloemenkamp KWM, Eikmans M.

J Reprod Immunol. 2018 Apr;126:46-52. doi: 10.1016/j.jri.2018.02.002. Epub 2018 Feb 7.

PMID:
29481987
10.

Maternal and child human leukocyte antigens in congenital cytomegalovirus infection.

Rovito R, Claas FHJ, Haasnoot GW, Roelen DL, Kroes ACM, Vossen ACTM.

J Reprod Immunol. 2018 Apr;126:39-45. doi: 10.1016/j.jri.2018.01.002. Epub 2018 Jan 31.

11.

Elevated intragraft expression of innate immunity and cell death-related markers is a risk factor for adverse graft outcome.

Yang J, Snijders MLH, Haasnoot GW, van Kooten C, Mallat M, de Fijter JW, Clahsen-van Groningen MC, Claas FHJ, Eikmans M.

Transpl Immunol. 2018 Jun;48:39-46. doi: 10.1016/j.trim.2018.02.009. Epub 2018 Feb 20.

PMID:
29475090
12.

Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JSF, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Am J Transplant. 2018 Feb 21. doi: 10.1111/ajt.14709. [Epub ahead of print]

PMID:
29464832
13.

HLA Class I Antigen Expression in Conjunctival Melanoma Is Not Associated With PD-L1/PD-1 Status.

Cao J, Brouwer NJ, Jordanova ES, Marinkovic M, van Duinen SG, de Waard NE, Ksander BR, Mulder A, Claas FHJ, Heemskerk MHM, Jager MJ.

Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):1005-1015. doi: 10.1167/iovs.17-23209.

PMID:
29450544
14.

HLA mismatches that are identical for the antigen recognition domain are less immunogenic.

Roelen D, de Vaal Y, Vierra-Green C, Waldvogel S, Spellman S, Claas F, Oudshoorn M.

Bone Marrow Transplant. 2018 Jun;53(6):729-740. doi: 10.1038/s41409-018-0108-6. Epub 2018 Feb 6.

PMID:
29410546
15.

Human and Rhesus Macaque KIR Haplotypes Defined by Their Transcriptomes.

Bruijnesteijn J, van der Wiel MKH, Swelsen WTN, Otting N, de Vos-Rouweler AJM, Elferink D, Doxiadis GG, Claas FHJ, Lardy NM, de Groot NG, Bontrop RE.

J Immunol. 2018 Mar 1;200(5):1692-1701. doi: 10.4049/jimmunol.1701480. Epub 2018 Jan 22.

PMID:
29358278
16.

Congenital Cytomegalovirus Infection: Maternal-Child HLA-C, HLA-E, and HLA-G Affect Clinical Outcome.

Rovito R, Claas FHJ, Haasnoot GW, Roelen DL, Kroes ACM, Eikmans M, Vossen ACTM.

Front Immunol. 2018 Jan 5;8:1904. doi: 10.3389/fimmu.2017.01904. eCollection 2017.

17.

Mixed signature of activation and dysfunction allows human decidual CD8+ T cells to provide both tolerance and immunity.

van der Zwan A, Bi K, Norwitz ER, Crespo ÂC, Claas FHJ, Strominger JL, Tilburgs T.

Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):385-390. doi: 10.1073/pnas.1713957115. Epub 2017 Dec 19.

18.

Response to the comments on "Direct quantitative measurement of the kinetics of HLA-specific antibody interactions with isolated HLA proteins".

Daga S, Moyse H, Briggs D, Lowe D, Evans N, Jones J, Buchli R, McMurtrey C, Mulder A, Hildebrand W, Claas F, Higgins R, Mitchell DA, Zehnder D.

Hum Immunol. 2018 Feb;79(2):130-131. doi: 10.1016/j.humimm.2017.12.001. Epub 2017 Dec 5. No abstract available.

PMID:
29217367
19.

Paternal HLA-C is a risk factor in unexplained recurrent miscarriage.

Meuleman T, Haasnoot GW, van Lith JMM, Verduijn W, Bloemenkamp KWM, Claas FHJ.

Am J Reprod Immunol. 2018 Feb;79(2). doi: 10.1111/aji.12797. Epub 2017 Dec 4.

PMID:
29205643
20.

Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity.

Meysman P, De Neuter N, Bartholomeus E, Elias G, Van den Bergh J, Emonds MP, Haasnoot GW, Heynderickx S, Wens J, Michels NR, Lambert J, Lion E, Claas FHJ, Goossens H, Smits E, Van Damme P, Van Tendeloo V, Beutels P, Suls A, Mortier G, Laukens K, Ogunjimi B.

Immunogenetics. 2018 Jun;70(6):363-372. doi: 10.1007/s00251-017-1047-x. Epub 2017 Dec 1.

PMID:
29196796
21.

Donor-specific anti-HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation.

den Dulk AC, Shi X, Verhoeven CJ, Dubbeld J, Claas FHJ, Wolterbeek R, Brand-Schaaf SH, Verspaget HW, Sarasqueta AF, van der Laan LJW, Metselaar HJ, van Hoek B, Kwekkeboom J, Roelen DL.

Clin Transplant. 2018 Feb;32(2). doi: 10.1111/ctr.13163. Epub 2017 Dec 23.

PMID:
29193362
22.

The avidity of cross-reactive virus-specific T cells for their viral and allogeneic epitopes is variable and depends on epitope expression.

van den Heuvel H, Heutinck KM, van der Meer-Prins EMW, Franke-van Dijk MEI, van Miert PPMC, Zhang X, Ten Berge IJM, Claas FHJ.

Hum Immunol. 2018 Jan;79(1):39-50. doi: 10.1016/j.humimm.2017.10.019. Epub 2017 Oct 31.

PMID:
29100943
23.

Direct quantitative measurement of the kinetics of HLA-specific antibody interactions with isolated HLA proteins.

Daga S, Moyse H, Briggs D, Lowe D, Evans N, Jones J, Buchli R, McMurtrey C, Mulder A, Hildebrand W, Claas F, Higgins R, Mitchell DA, Zehnder D.

Hum Immunol. 2018 Feb;79(2):122-128. doi: 10.1016/j.humimm.2017.10.012. Epub 2017 Oct 31.

PMID:
29097266
24.

Platelets from donors with consistently low HLA-B8, -B12, or -B35 expression do not undergo antibody-mediated internalization.

Saris A, Tomson B, Brand A, Mulder A, Claas FH, Lorinser J, Scharenberg J, van Ham SM, Ten Brinke A, Zwaginga JJ, van der Meer PF.

Blood. 2018 Jan 4;131(1):144-152. doi: 10.1182/blood-2017-07-799270. Epub 2017 Nov 1.

PMID:
29092829
25.

Novel aspects of epitope matching and practical application in kidney transplantation.

Lim WH, Wong G, Heidt S, Claas FHJ.

Kidney Int. 2018 Feb;93(2):314-324. doi: 10.1016/j.kint.2017.08.008. Epub 2017 Oct 20.

PMID:
29061333
26.

Obituary: Prof Johannes Joseph van Rood (1926-2017).

Brand A, Claas FHJ, Bontrop RE, de Vries RRP.

Vox Sang. 2018 Jan;113(1):89-91. doi: 10.1111/vox.12604. Epub 2017 Oct 16. No abstract available.

PMID:
29034478
27.

Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.

Heidt S, Haasnoot GW, van Rood JJ, Witvliet MD, Claas FHJ.

Kidney Int. 2018 Feb;93(2):491-500. doi: 10.1016/j.kint.2017.07.018. Epub 2017 Sep 22.

PMID:
28947279
28.

The Humoral Theory of Transplantation.

Ravindranath MH, Cai J, Ferrone S, Claas FHJ, Selvan SR.

J Immunol Res. 2017;2017:5935123. doi: 10.1155/2017/5935123. Epub 2017 Aug 8. No abstract available.

29.

KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-C.

Naiyer MM, Cassidy SA, Magri A, Cowton V, Chen K, Mansour S, Kranidioti H, Mbirbindi B, Rettman P, Harris S, Fanning LJ, Mulder A, Claas FHJ, Davidson AD, Patel AH, Purbhoo MA, Khakoo SI.

Sci Immunol. 2017 Sep 15;2(15). pii: eaal5296. doi: 10.1126/sciimmunol.aal5296.

PMID:
28916719
30.

The seed to success: The role of seminal plasma in pregnancy.

Nederlof I, Meuleman T, van der Hoorn MLP, Claas FHJ, Eikmans M.

J Reprod Immunol. 2017 Sep;123:24-28. doi: 10.1016/j.jri.2017.08.008. Epub 2017 Aug 24. Review.

PMID:
28886486
31.

Prof. Dr. Johannes Joseph van Rood (1926-2017).

Bontrop RE, Brand A, Claas FHJ.

HLA. 2017 Oct;90(4):207-210. doi: 10.1111/tan.13113. No abstract available.

32.

Multiple E2 ubiquitin-conjugating enzymes regulate human cytomegalovirus US2-mediated immunoreceptor downregulation.

van de Weijer ML, Schuren ABC, van den Boomen DJH, Mulder A, Claas FHJ, Lehner PJ, Lebbink RJ, Wiertz EJHJ.

J Cell Sci. 2017 Sep 1;130(17):2883-2892. doi: 10.1242/jcs.206839. Epub 2017 Jul 25.

33.

Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms.

D'Orsogna L, van den Heuvel H, van Kooten C, Heidt S, Claas FHJ.

Immunogenetics. 2017 Aug;69(8-9):631-641. doi: 10.1007/s00251-017-0989-3. Epub 2017 Jul 17. Review.

34.

Fibroblast-adapted human CMV vaccines elicit predominantly conventional CD8 T cell responses in humans.

Murray SE, Nesterenko PA, Vanarsdall AL, Munks MW, Smart SM, Veziroglu EM, Sagario LC, Lee R, Claas FHJ, Doxiadis IIN, McVoy MA, Adler SP, Hill AB.

J Exp Med. 2017 Jul 3;214(7):1889-1899. doi: 10.1084/jem.20161988. Epub 2017 May 31.

35.

When selecting a cord blood unit from a firstborn donor verify that the patient shares an Ag with the unit that is foreign to the mother of the donor.

van Rood JJ, Brand A, Scaradavou A, Claas FH, Oudshoorn M, Stevens CE.

Bone Marrow Transplant. 2017 Jul;52(7):1039-1040. doi: 10.1038/bmt.2017.75. Epub 2017 Apr 24. No abstract available.

PMID:
28436971
36.

Defining the immunogenicity and antigenicity of HLA epitopes is crucial for optimal epitope matching in clinical renal transplantation.

Kramer CSM, Roelen DL, Heidt S, Claas FHJ.

HLA. 2017 Jul;90(1):5-16. doi: 10.1111/tan.13038. Epub 2017 Apr 5. Review.

PMID:
28378521
37.

Stimulation of HIV-specific T cell clonotypes using allogeneic HLA.

Almeida CA, van Miert P, O'Driscoll K, Zoet YM, Chopra A, Watson M, de Santis D, Witt C, John M, Claas FHJ, D'Orsogna LJ.

Cell Immunol. 2017 Jun;316:32-40. doi: 10.1016/j.cellimm.2017.03.004. Epub 2017 Mar 28.

PMID:
28372798
38.

A Memory B Cell Crossmatch Assay for Quantification of Donor-Specific Memory B Cells in the Peripheral Blood of HLA-Immunized Individuals.

Karahan GE, de Vaal YJH, Krop J, Wehmeier C, Roelen DL, Claas FHJ, Heidt S.

Am J Transplant. 2017 Oct;17(10):2617-2626. doi: 10.1111/ajt.14293. Epub 2017 May 3.

PMID:
28371365
39.

Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients.

Bank JR, Heidt S, Moes DJ, Roelen DL, Mallat MJ, van der Boog PJ, Vergunst M, Jol-van der Zijde CM, Bredius RG, Braat AE, Ringers J, van Tol MJ, Claas FH, Reinders ME, de Fijter JW.

Transplant Direct. 2016 Dec 19;3(1):e124. doi: 10.1097/TXD.0000000000000634. eCollection 2017 Jan.

40.

Allo-HLA Cross-Reactivities of Cytomegalovirus-, Influenza-, and Varicella Zoster Virus-Specific Memory T Cells Are Shared by Different Healthy Individuals.

van den Heuvel H, Heutinck KM, van der Meer-Prins EMW, Yong SL, van Miert PPMC, Anholts JDH, Franke-van Dijk MEI, Zhang XQ, Roelen DL, Ten Berge RJM, Claas FHJ.

Am J Transplant. 2017 Aug;17(8):2033-2044. doi: 10.1111/ajt.14279. Epub 2017 May 19.

PMID:
28332333
41.

Epitope-Based HLA Matching: A Useful Strategy With Many Shortcomings to Overcome.

Claas FHJ, Heidt S.

Transplantation. 2017 Aug;101(8):1744-1745. doi: 10.1097/TP.0000000000001705. No abstract available.

PMID:
28252563
42.

B Cell Immunity in Solid Organ Transplantation.

Karahan GE, Claas FH, Heidt S.

Front Immunol. 2017 Jan 10;7:686. doi: 10.3389/fimmu.2016.00686. eCollection 2016. Review.

43.

Modification of host dendritic cells by microchimerism-derived extracellular vesicles generates split tolerance.

Bracamonte-Baran W, Florentin J, Zhou Y, Jankowska-Gan E, Haynes WJ, Zhong W, Brennan TV, Dutta P, Claas FH, van Rood JJ, Burlingham WJ.

Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1099-1104. doi: 10.1073/pnas.1618364114. Epub 2017 Jan 17.

44.

Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response.

van Bergen CA, van Luxemburg-Heijs SA, de Wreede LC, Eefting M, von dem Borne PA, van Balen P, Heemskerk MH, Mulder A, Claas FH, Navarrete MA, Honders WM, Rutten CE, Veelken H, Jedema I, Halkes CJ, Griffioen M, Falkenburg JH.

J Clin Invest. 2017 Feb 1;127(2):517-529. doi: 10.1172/JCI86175. Epub 2017 Jan 9.

45.

Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4.

van Sonderen A, Roelen DL, Stoop JA, Verdijk RM, Haasnoot GW, Thijs RD, Wirtz PW, Schreurs MW, Claas FH, Sillevis Smitt PA, Titulaer MJ.

Ann Neurol. 2017 Feb;81(2):193-198. doi: 10.1002/ana.24858. Epub 2017 Jan 27.

PMID:
28026046
46.

Donor Genotype and Intragraft Expression of CYP3A5 Reflect the Response to Steroid Treatment During Acute Renal Allograft Rejection.

Rekers NV, Flaig TM, Mallat MJK, Spruyt-Gerritse MJ, Zandbergen M, Anholts JDH, Bajema IM, Clahsen-van Groningen MC, Yang J, de Fijter JW, Claas FHJ, Brakemeier S, Lachmann N, Kreutz R, de Heer E, Budde K, Bolbrinker J, Eikmans M.

Transplantation. 2017 Sep;101(9):2017-2025. doi: 10.1097/TP.0000000000001584.

PMID:
27926596
47.

Association of high HLA-E expression during acute cellular rejection and numbers of HLA class I leader peptide mismatches with reduced renal allograft survival.

Guberina H, Rebmann V, Wagner B, da Silva Nardi F, Dziallas P, Dolff S, Bienholz A, Wohlschlaeger J, Bankfalvi A, Heinemann FM, Witzke O, Zoet YM, Claas FH, Horn PA, Kribben A, Doxiadis II.

Immunobiology. 2017 Mar;222(3):536-543. doi: 10.1016/j.imbio.2016.10.021. Epub 2016 Nov 4.

PMID:
27871782
48.

Identification of Donor Origin and Condition of Transplanted Islets In Situ in the Liver of a Type 1 Diabetic Recipient.

van der Torren CR, Suwandi JS, Lee D, Van't Wout ET, Duinkerken G, Swings G, Mulder A, Claas FH, Ling Z, Gillard P, Keymeulen B, In't Veld P, Roep BO.

Cell Transplant. 2017 Jan 24;26(1):1-9. doi: 10.3727/096368916X693437. Epub 2016 Oct 10.

49.

Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.

Romee R, Rosario M, Berrien-Elliott MM, Wagner JA, Jewell BA, Schappe T, Leong JW, Abdel-Latif S, Schneider SE, Willey S, Neal CC, Yu L, Oh ST, Lee YS, Mulder A, Claas F, Cooper MA, Fehniger TA.

Sci Transl Med. 2016 Sep 21;8(357):357ra123. doi: 10.1126/scitranslmed.aaf2341.

50.

Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD.

Carapito R, Jung N, Kwemou M, Untrau M, Michel S, Pichot A, Giacometti G, Macquin C, Ilias W, Morlon A, Kotova I, Apostolova P, Schmitt-Graeff A, Cesbron A, Gagne K, Oudshoorn M, van der Holt B, Labalette M, Spierings E, Picard C, Loiseau P, Tamouza R, Toubert A, Parissiadis A, Dubois V, Lafarge X, Maumy-Bertrand M, Bertrand F, Vago L, Ciceri F, Paillard C, Querol S, Sierra J, Fleischhauer K, Nagler A, Labopin M, Inoko H, von dem Borne PA, Kuball J, Ota M, Katsuyama Y, Michallet M, Lioure B, Peffault de Latour R, Blaise D, Cornelissen JJ, Yakoub-Agha I, Claas F, Moreau P, Milpied N, Charron D, Mohty M, Zeiser R, Socié G, Bahram S.

Blood. 2016 Oct 13;128(15):1979-1986. Epub 2016 Aug 22.

Supplemental Content

Support Center